• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用弱监督深度学习模型检测磁共振成像不可见的前列腺癌

Detecting MRI-Invisible Prostate Cancers Using a Weakly Supervised Deep Learning Model.

作者信息

Zheng Yao, Zhang Jingliang, Huang Dong, Hao Xiaoshuo, Qin Weijun, Liu Yang

机构信息

School of Biomedical Engineering, Air Force Medical University, No. 169 Changle West Road, Xi'an, Shaanxi, China.

Department of Urology, Xijing Hospital, Air Force Medical University, No. 127 Changle West Road, Xi'an, Shaanxi Province, China.

出版信息

Int J Biomed Imaging. 2024 Mar 19;2024:2741986. doi: 10.1155/2024/2741986. eCollection 2024.

DOI:10.1155/2024/2741986
PMID:38532840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10965281/
Abstract

BACKGROUND

MRI is an important tool for accurate detection and targeted biopsy of prostate lesions. However, the imaging appearances of some prostate cancers are similar to those of the surrounding normal tissue on MRI, which are referred to as MRI-invisible prostate cancers (MIPCas). The detection of MIPCas remains challenging and requires extensive systematic biopsy for identification. In this study, we developed a weakly supervised UNet (WSUNet) to detect MIPCas.

METHODS

The study included 777 patients (training set: 600; testing set: 177), all of them underwent comprehensive prostate biopsies using an MRI-ultrasound fusion system. MIPCas were identified in MRI based on the Gleason grade (≥7) from known systematic biopsy results.

RESULTS

The WSUNet model underwent validation through systematic biopsy in the testing set with an AUC of 0.764 (95% CI: 0.728-0.798). Furthermore, WSUNet exhibited a statistically significant precision improvement of 91.3% ( < 0.01) over conventional systematic biopsy methods in the testing set. This improvement resulted in a substantial 47.6% ( < 0.01) decrease in unnecessary biopsy needles, while maintaining the same number of positively identified cores as in the original systematic biopsy.

CONCLUSIONS

In conclusion, the proposed WSUNet could effectively detect MIPCas, thereby reducing unnecessary biopsies.

摘要

背景

磁共振成像(MRI)是准确检测前列腺病变并进行靶向活检的重要工具。然而,一些前列腺癌在MRI上的影像表现与周围正常组织相似,这些被称为MRI隐匿性前列腺癌(MIPCas)。MIPCas的检测仍然具有挑战性,需要进行广泛的系统活检来识别。在本研究中,我们开发了一种弱监督UNet(WSUNet)来检测MIPCas。

方法

该研究纳入了777例患者(训练集:600例;测试集:177例),所有患者均使用MRI-超声融合系统进行了全面的前列腺活检。根据已知系统活检结果的Gleason分级(≥7)在MRI中识别MIPCas。

结果

WSUNet模型在测试集中通过系统活检进行了验证,AUC为0.764(95%CI:0.728 - 0.798)。此外,在测试集中,WSUNet相对于传统系统活检方法在统计学上表现出显著的精度提高,提高了91.3%(<0.01)。这种提高使得不必要的活检针数大幅减少了47.6%(<0.01),同时保持与原始系统活检中阳性识别核心数量相同。

结论

总之,所提出的WSUNet可以有效检测MIPCas,从而减少不必要的活检。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/093848dc4f94/IJBI2024-2741986.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/c3806e62ce58/IJBI2024-2741986.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/05aab0ebf11e/IJBI2024-2741986.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/5771cb85e3f3/IJBI2024-2741986.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/238569d24ec3/IJBI2024-2741986.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/924544ff75dd/IJBI2024-2741986.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/09d7eaa90986/IJBI2024-2741986.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/7b3ad3c11812/IJBI2024-2741986.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/c9e77488c792/IJBI2024-2741986.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/093848dc4f94/IJBI2024-2741986.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/c3806e62ce58/IJBI2024-2741986.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/05aab0ebf11e/IJBI2024-2741986.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/5771cb85e3f3/IJBI2024-2741986.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/238569d24ec3/IJBI2024-2741986.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/924544ff75dd/IJBI2024-2741986.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/09d7eaa90986/IJBI2024-2741986.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/7b3ad3c11812/IJBI2024-2741986.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/c9e77488c792/IJBI2024-2741986.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c1e/10965281/093848dc4f94/IJBI2024-2741986.009.jpg

相似文献

1
Detecting MRI-Invisible Prostate Cancers Using a Weakly Supervised Deep Learning Model.使用弱监督深度学习模型检测磁共振成像不可见的前列腺癌
Int J Biomed Imaging. 2024 Mar 19;2024:2741986. doi: 10.1155/2024/2741986. eCollection 2024.
2
Weakly supervised segmentation models as explainable radiological classifiers for lung tumour detection on CT images.弱监督分割模型作为用于CT图像上肺肿瘤检测的可解释放射学分类器
Insights Imaging. 2023 Nov 19;14(1):195. doi: 10.1186/s13244-023-01542-2.
3
Augmenting MRI-transrectal ultrasound-guided prostate biopsy with temporal ultrasound data: a clinical feasibility study.利用颞部超声数据增强MRI经直肠超声引导下的前列腺活检:一项临床可行性研究。
Int J Comput Assist Radiol Surg. 2015 Jun;10(6):727-35. doi: 10.1007/s11548-015-1184-3. Epub 2015 Apr 7.
4
Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.前瞻性随机临床试验比较了磁共振成像(MRI)引导的腔内活检与 MRI-超声融合和经直肠超声引导的前列腺活检在先前阴性活检患者中的应用。
Eur Urol. 2015 Oct;68(4):713-20. doi: 10.1016/j.eururo.2015.06.008. Epub 2015 Jun 23.
5
Multiparametric MRI in detection and staging of prostate cancer.多参数磁共振成像在前列腺癌检测与分期中的应用
Dan Med J. 2017 Feb;64(2).
6
Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection.初始活检前磁共振成像的作用:比较磁共振成像靶向与系统活检在检出显著前列腺癌中的作用。
BJU Int. 2011 Oct;108(8 Pt 2):E171-8. doi: 10.1111/j.1464-410X.2011.10112.x. Epub 2011 Mar 22.
7
MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.MRI/超声融合引导下的前列腺活检在初诊患者中能够检测出同等数量的癌症,且穿刺针数显著减少。
Diagn Interv Radiol. 2018 May-Jun;24(3):115-120. doi: 10.5152/dir.2018.17422.
8
Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy.优化前列腺磁共振成像融合靶向活检的靶向核心数量。
Eur Urol Oncol. 2018 Oct;1(5):418-425. doi: 10.1016/j.euo.2018.09.006. Epub 2018 Oct 5.
9
An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study.采用磁共振成像与前列腺特异性抗原联合检测的筛查途径评估:来自 IP1-PROSTAGRAM 研究的结果。
Eur Urol Oncol. 2023 Jun;6(3):295-302. doi: 10.1016/j.euo.2023.03.009. Epub 2023 Apr 18.
10
Selective identification and localization of indolent and aggressive prostate cancers via CorrSigNIA: an MRI-pathology correlation and deep learning framework.通过 CorrSigNIA 选择性识别和定位惰性和侵袭性前列腺癌:一种 MRI-病理学相关性和深度学习框架。
Med Image Anal. 2022 Jan;75:102288. doi: 10.1016/j.media.2021.102288. Epub 2021 Nov 6.

引用本文的文献

1
Editorial for the Special Issue "Advances in Medical Image Processing, Segmentation, and Classification".《医学图像处理、分割与分类进展》特刊社论
Diagnostics (Basel). 2025 Apr 28;15(9):1114. doi: 10.3390/diagnostics15091114.

本文引用的文献

1
Artificial intelligence applications in prostate cancer.人工智能在前列腺癌中的应用。
Prostate Cancer Prostatic Dis. 2024 Mar;27(1):37-45. doi: 10.1038/s41391-023-00684-0. Epub 2023 Jun 9.
2
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study.在原发性联合 MRI 靶向活检中,系统活检在诊断临床显著前列腺癌中的当前作用:一项大容量单中心研究。
World J Urol. 2023 Jan;41(1):19-25. doi: 10.1007/s00345-022-04230-w. Epub 2022 Dec 7.
4
Site-specific concordance of targeted and systematic biopsy cores at the index lesion on multiparametric magnetic resonance: can we spare the double-tap?多参数磁共振成像时靶向活检与系统活检在索引病灶处特定部位的一致性:我们能否省去二次活检?
World J Urol. 2023 Jan;41(1):27-33. doi: 10.1007/s00345-022-04229-3. Epub 2022 Dec 5.
5
A review of artificial intelligence in prostate cancer detection on imaging.关于人工智能在前列腺癌影像检测中的综述。
Ther Adv Urol. 2022 Oct 10;14:17562872221128791. doi: 10.1177/17562872221128791. eCollection 2022 Jan-Dec.
6
Prostate specific membrane antigen positron emission tomography in primary prostate cancer diagnosis: First-line imaging is afoot.前列腺特异性膜抗原正电子发射断层扫描在原发性前列腺癌诊断中的应用:一线影像学方法正在发展中。
Cancer Lett. 2022 Nov 1;548:215883. doi: 10.1016/j.canlet.2022.215883. Epub 2022 Aug 24.
7
Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019.前列腺癌发病率和死亡率:2000 年至 2019 年 89 个国家的全球状况和时间趋势。
Front Public Health. 2022 Feb 16;10:811044. doi: 10.3389/fpubh.2022.811044. eCollection 2022.
8
Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.经会阴模板引导式饱和与靶向前列腺活检的男性前列腺癌检出率。
Prostate. 2022 Feb;82(3):388-396. doi: 10.1002/pros.24286. Epub 2021 Dec 16.
9
Deep learning-assisted prostate cancer detection on bi-parametric MRI: minimum training data size requirements and effect of prior knowledge.深度学习辅助双参数 MRI 前列腺癌检测:最小训练数据量要求及先验知识的影响。
Eur Radiol. 2022 Apr;32(4):2224-2234. doi: 10.1007/s00330-021-08320-y. Epub 2021 Nov 16.
10
Why Does Magnetic Resonance Imaging-Targeted Biopsy Miss Clinically Significant Cancer?磁共振成像引导下的靶向活检为何会漏诊有临床意义的癌症?
J Urol. 2022 Jan;207(1):95-107. doi: 10.1097/JU.0000000000002182. Epub 2021 Aug 26.